TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 49 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $158,000 | -61.1% | 50,000 | -91.9% | 0.00% | – |
| Q2 2023 | $406,474 | +106866.8% | 614,938 | +28.9% | 0.00% | – |
| Q1 2023 | $380 | -56.5% | 477,045 | +23.4% | 0.00% | – |
| Q4 2022 | $874 | -99.7% | 386,589 | +121.7% | 0.00% | – |
| Q3 2022 | $337,000 | -58.1% | 174,378 | -19.3% | 0.00% | – |
| Q2 2022 | $804,000 | +14.9% | 216,168 | +260.0% | 0.00% | – |
| Q4 2021 | $700,000 | +9.5% | 60,049 | +99.1% | 0.00% | – |
| Q2 2021 | $639,000 | +49.0% | 30,165 | +42.8% | 0.00% | – |
| Q1 2021 | $429,000 | -16.7% | 21,125 | +8.9% | 0.00% | – |
| Q4 2020 | $515,000 | -86.7% | 19,400 | -88.8% | 0.00% | -100.0% |
| Q3 2020 | $3,881,000 | – | 173,257 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,391,190 | $29,493,000 | 22.62% |
| Octagon Capital Advisors LP | 320,440 | $6,793,000 | 1.41% |
| Artal Group S.A. | 1,040,882 | $22,067,000 | 0.45% |
| Alphabet Inc. | 640,882 | $13,587,000 | 0.28% |
| Nantahala Capital Management | 432,072 | $9,160,000 | 0.26% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $10,600,000 | 0.22% |
| TimesSquare Capital Management, LLC | 683,400 | $14,488,000 | 0.12% |
| Perceptive Advisors | 640,880 | $13,586,000 | 0.09% |
| Virtus ETF Advisers LLC | 8,697 | $184,000 | 0.08% |
| Granite Point Capital Management, L.P. | 50,000 | $1,060,000 | 0.04% |